首页> 美国卫生研究院文献>EXCLI Journal >Cellular uptake and anti-tumor activity of gemcitabine conjugated with new amphiphilic cell penetrating peptides
【2h】

Cellular uptake and anti-tumor activity of gemcitabine conjugated with new amphiphilic cell penetrating peptides

机译:吉西他滨与新型两亲性细胞穿透肽结合的细胞吸收和抗肿瘤活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gemcitabine (Gem) is used as a single agent or in combination with other anticancer agents to treat many types of solid tumors. However, it has many limitations such as a short plasma half-life, dose-limiting toxicities and drug resistance. Cell-penetrating peptides (CPPs) are short peptides which may deliver a large variety of cargo molecules into the cancerous cells. The current study was designed to evaluate the antiproliferative activity of gemcitabine chemically conjugated to CPPs. The peptides were synthesized using solid phase synthesis procedure. The uptake efficiency of CPPs into cells was examined by flow cytometry and fluorescent microscopy. The synthesized peptides were chemically conjugated to Gem and the in vitro cytotoxicity of conjugates was tested by MTT assay on A594 cell line. According to the obtained results, cellular uptake was increased with increasing the concentration of CPPs. On the other hand the coupling of Gem with peptides containing block sequence of arginine (R5W3R4) and some alternating sequences (i.e. [RW]6 and [RW]3) exhibited improved antitumor activity of the drug. The findings in this study support the advantages of using cell-penetrating peptides for improving intracellular delivery of Gem into tumor as well as its activity.
机译:吉西他滨(Gem)可作为单一药物或与其他抗癌药物联合使用,以治疗多种类型的实体瘤。但是,它具有许多局限性,例如血浆半衰期短,剂量限制的毒性和耐药性。细胞穿透肽(CPPs)是短肽,可以将多种货物分子输送到癌细胞中。本研究旨在评估化学偶联于CPP的吉西他滨的抗增殖活性。使用固相合成方法合成肽。通过流式细胞术和荧光显微镜检查CPPs吸收到细胞中的效率。将合成的肽化学缀合至宝石,并通过MTT测定法在A594细胞系上测试缀合物的体外细胞毒性。根据获得的结果,细胞吸收随着CPPs浓度的增加而增加。另一方面,Gem与含有精氨酸的嵌段序列(R5W3R4)和一些交替序列(即[RW] 6和[RW] 3)的肽的偶联表现出改进的药物抗肿瘤活性。这项研究中的发现支持使用细胞穿透肽改善宝石向肿瘤内的细胞内传递及其活性的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号